Newmont Equity Method Investments decreased by 99.4% to $25.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 99.5%, from $4.86B to $25.00M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 5.5% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.22B | $3.17B | $3.24B | $3.34B | $3.20B | $3.20B | $3.28B | $3.22B | $3.17B | $3.13B | $4.14B | $4.14B | $4.14B | $4.15B | $4.47B | $4.86B | $4.46B | $4.10B | $4.19B | $25.00M |
| QoQ Change | — | -1.5% | +2.2% | +2.8% | -4.0% | -0.2% | +2.5% | -1.9% | -1.4% | -1.2% | +32.2% | -0.1% | +0.1% | +0.2% | +7.7% | +8.6% | -8.3% | -7.9% | +2.0% | -99.4% |
| YoY Change | — | — | — | — | -0.5% | +0.8% | +1.1% | -3.6% | -1.0% | -2.0% | +26.4% | +28.7% | +30.5% | +32.5% | +7.9% | +17.4% | +7.6% | -1.1% | -6.4% | -99.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.